Literature DB >> 30456471

[Pain in old age].

Thomas Hubert Cegla1, Johannes Horlemann2.   

Abstract

The prevalence of chronic pain increases with increasing age. Multimorbidity increases the risk of disease-related pain. Addressing the problem of pain in higher age is concerned with an increasing problem of care. The multimorbidity and the resulting multimedication are important for the medical care of pain. The therefore necessary physician-patient verbal communication can hardly be remunerated and carried out in the current care landscape. Existing resources must be bundled. The quality of life of older people and not the absence of pain, must be emphasized. Particularly problematic is the recognition and treatment of pain in patients with dementia. Pain in dementia patients is more rarely detected. In addition to questioning relatives and caregivers, a structured pain interview is necessary. The pharmacology of chronic pain is concerned above all with the prevention of iatrogenic risks through interactions and pharmacological complications. The patient-related treatment priorities must be checked and adjusted during the course of treatment. To be considered are age-related altered metabolic pathways. A sensible therapy option is the training of physical activity with a positive effect on the entire pain experience. Behavioral medical treatment procedures are other important building blocks in pain therapy. In addition to the multimodal therapeutic approaches, a stronger interdisciplinary collaboration of special pain medicine and geriatrics is necessary.

Entities:  

Keywords:  Chronic pain; Health care; Interdisciplinarity; Multimorbidity; Polypharmacy

Mesh:

Year:  2018        PMID: 30456471     DOI: 10.1007/s00391-018-01477-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  18 in total

Review 1.  [Antiepileptic drug-induced encephalopathy].

Authors:  N Hansen; M Finzel; F Block
Journal:  Fortschr Neurol Psychiatr       Date:  2010-10-06       Impact factor: 0.752

2.  Tailoring cognitive-behavioral therapy for chronic pain: a case example.

Authors:  Alicia A Heapy; Michael W Stroud; Diana M Higgins; John J Sellinger
Journal:  J Clin Psychol       Date:  2006-11

Review 3.  [Status and perspectives of pain and pain therapy in old age : Plea for better care of geriatric pain patients].

Authors:  Corinna Drebenstedt; Matthias Schuler
Journal:  Z Gerontol Geriatr       Date:  2017-09-21       Impact factor: 1.281

Review 4.  Topical analgesics for neuropathic pain in the elderly: current and future prospects.

Authors:  Jana Sawynok
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

5.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

6.  [Prevalence of chronic pain in Germany. A representative survey of the general population].

Authors:  W Häuser; G Schmutzer; A Hinz; A Hilbert; E Brähler
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

7.  Experience in the diagnosis of headaches that start in elderly people.

Authors:  J Pascual; J Berciano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

Review 8.  Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.

Authors:  Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2014-08-28       Impact factor: 2.953

9.  [Prevalence and predictors of pain in several body regions. Results of a representative German population survey].

Authors:  W Häuser; G Schmutzer; H Glaesmer; E Brähler
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

10.  [The prevalence of pain in the elderly German population: results of population-based studies with the Giessen Subjective Complaints List (Giessener Beschwerdebogen GBB)].

Authors:  T Gunzelmann; J Schumacher; E Brähler
Journal:  Schmerz       Date:  2002-08       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.